ArticleCancers2023

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium-177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience.

Zenaide Silva de Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.